Teyi Pharmaceutical Group Co., Ltd. (002728) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Teyi Pharmaceutical Group Co., Ltd.

Why is Teyi Pharmaceutical Group Co., Ltd. ?

With a growth in Operating Profit of 245.89%, the company declared Very Positive results in Mar 25

RAW MATERIAL COST(Y) Fallen by -65.66% (YoY)
NET SALES(Q) Highest at CNY 290.79 MM
OPERATING PROFIT(Q) Highest at CNY 38.93 MM

With ROE of 3.15%, it has a fair valuation with a 1.80 Price to Book Value

Over the past year, while the stock has generated a return of 23.80%, its profits have fallen by -51.6%

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Teyi Pharmaceutical Group Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Teyi Pharmaceutical Group Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Teyi Pharmaceutical Group Co., Ltd.

42.84%

1.17

35.76%

China Shanghai Composite

14.77%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.06%

EBIT Growth (5y)

-15.09%

EBIT to Interest (avg)

8.54

Debt to EBITDA (avg)

0.88

Net Debt to Equity (avg)

-0.01

Sales to Capital Employed (avg)

0.40

Tax Ratio

14.65%

Dividend Payout Ratio

121.95%

Pledged Shares

Institutional Holding

ROCE (avg)

9.69%

ROE (avg)

9.04%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.80

EV to EBIT

49.79

EV to EBITDA

24.21

EV to Capital Employed

1.81

EV to Sales

3.69

PEG Ratio

Dividend Yield

0.50%

ROCE (Latest)

3.64%

ROE (Latest)

3.15%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -65.66% (YoY

NET SALES(Q)

Highest at CNY 290.79 MM

OPERATING PROFIT(Q)

Highest at CNY 38.93 MM

PRE-TAX PROFIT(Q)

Highest at CNY 39.42 MM

NET PROFIT(Q)

Highest at CNY 31.57 MM

EPS(Q)

Highest at CNY 0.06

-18What is not working for the Company

NET PROFIT(HY)

At CNY 46.05 MM has Grown at -46.12%

OPERATING CASH FLOW(Y)

Lowest at CNY 109.94 MM

ROCE(HY)

Lowest at 2.25%

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.47%

INTEREST(Q)

At CNY 1.85 MM has Grown at 40.57%

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.75%

Here's what is working for Teyi Pharmaceutical Group Co., Ltd.

Pre-Tax Profit

At CNY 39.42 MM has Grown at 252.13%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 31.57 MM has Grown at 244.82%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Net Sales

At CNY 290.79 MM has Grown at 78.34%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (CNY MM)

Net Sales

Highest at CNY 290.79 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit

Highest at CNY 38.93 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Pre-Tax Profit

Highest at CNY 39.42 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 31.57 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.06

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -65.66% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Teyi Pharmaceutical Group Co., Ltd.

Operating Cash Flow

Lowest at CNY 109.94 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest

At CNY 1.85 MM has Grown at 40.57%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Inventory Turnover Ratio

Lowest at 1.47% and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 4.75%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio